Contact

Representative before the EPO

Company dna urquhart dykes and lord llp
no operation time available
6 offices
active in Legal Services

We have observed 45 EP applications Simon James Mitchell has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11827315

AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS

IPC classification:
A61K 31/7052, A61P 31/12, C07H 19/04, C07H 19/056, C07H 19/06
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP10854669

PROCESS FOR CINACALCET HYDROCHLORIDE

IPC classification:
C07C 211/00
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11840517

NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM

IPC classification:
C07D 215/16
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP10852079

SALTS OF RALTEGRAVIR

IPC classification:
A01N 43/54, A61K 31/505, C07D 413/12
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11830290

PROCESS FOR PREPARING TOLVAPTAN INTERMEDIATES

IPC classification:
A01N 43/00, C07D 223/16
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11827318

SUBSTITUTED NUCLEOTIDE ANALOGS

IPC classification:
A61K 31/7068, A61K 31/7076, A61K 31/708, A61P 31/12, A61P 31/14, A61P 31/16, C07F 9/165, C07H 19/06, C07H 19/10, C07H 19/16, C07H 19/20
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11838957

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

IPC classification:
A61K 9/48, A61K 31/505, A61K 31/506, A61K 31/635, A61P 7/00
Agent:
Andrea Birgit Coles, Kilburn & Strode LLP
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP12831918

RILPIVIRINE HYDROCHLORIDE

IPC classification:
C07D 239/48
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12836162

NOVEL SALTS OF ALOGLIPTIN

IPC classification:
C07D 401/04
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12766060

INSECTICIDAL 2-METHOXYBENZAMIDE DERIVATIVES

IPC classification:
A01N 43/40, A01P 5/00, A01P 7/02, A01P 7/04, A01P 9/00, C07D 213/81, C07D 213/82
Applicant:
Syngenta Participations AG
Agent:
Syngenta International AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP12848616

AN EXTENDED RELEASE FORMULATION OF A DIRECT THROMBIN INHIBITOR

IPC classification:
A61K 31/4965
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13738230

COMPOSITIONS AND METHODS RELATING TO LYME DISEASE

IPC classification:
C07K 14/195, G01N 33/50, G01N 33/68
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12777436

NEUTRALIZING ANTIBODIES TO NIPAH AND HENDRA VIRUS

IPC classification:
A61K 39/00, C07K 16/10
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Fanelli Haag & Kilger PLLC
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
APPLICATION WITHDRAWN
EP13723629

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/00, A61K 9/10, A61K 31/56, A61K 47/26, A61K 47/34
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13723350

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/10, A61K 9/51, A61K 47/32
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13724670

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/10, A61K 9/51, A61K 47/34
Applicant:
Johns Hopkins University
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13855714

GONORRHEAL MTRE PEPTIDES AND VACCINES

IPC classification:
A61K 38/00, A61K 39/00, A61K 39/40
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13831444

PLACENTAL VACCINATION THERAPY FOR CANCER

IPC classification:
A61K 35/50, A61P 35/00, A61P 37/04, C12N 5/073
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13865366

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

IPC classification:
A61K 31/7052, A61P 31/14, C07H 19/167, C07H 19/20
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14751929

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/47, A61K 31/4709, C07D 215/233
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14754329

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
C07D 215/233
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14181812

Providing information to a user through somatosensory feedback

IPC classification:
A61F 11/04
Applicant:
Baylor College of Medicine
Applicant:
William Marsh Rice University
Agent:
Dominic Forsythe, J A Kemp
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14762750

MEROPENEM DERIVATIVES AND USES THEREOF

IPC classification:
A61K 31/407, C07D 477/20, C07D 487/04
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP11845075

A PROCESS FOR THE PREPARATION OF PAZOPANIB USING NOVEL INTERMEDIATE

IPC classification:
C07D 403/02
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14843298

PYRIDAZINONE COMPOUNDS AND USES THEREOF

IPC classification:
C07D 237/24, C07D 401/04, C07D 401/08, C07D 401/10, C07D 401/12, C07D 403/04, C07D 403/06, C07D 403/08, C07D 403/10, C07D 403/12, C07D 405/04, C07D 405/06, C07D 405/10, C07D 405/12, C07D 409/10, C07D 409/12, C07D 413/06, C07D 471/04, C07D 473/00, C07D 487/04
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14844961

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/4985, A61P 31/14, A61P 31/16, C07D 487/04
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14837913

ANTIVIRAL COMPOUNDS

IPC classification:
C07D 207/267, C07D 213/40, C07D 233/58, C07D 239/34, C07D 277/28, C07D 401/04, C07D 401/06, C07D 401/12, C07D 405/12, C07D 409/04, C07D 409/14, C07D 413/04, C07D 413/12, C07D 417/04, C07D 417/06, C07D 417/12, C07D 471/04, C07D 487/04, C07D 491/048, C07D 491/052
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14850483

METHOD FOR REVERSING RECENT-ONSET TYPE 1 DIABETES (T1D) BY ADMINISTERING SUBSTANCE P (SP)

IPC classification:
A61K 31/00, A61K 31/165, A61P 3/00
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Lecomte & Partners Sàrl
Status:
EXAMINATION REQUESTED
EP14857737

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/48
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14857110

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/54, A61K 31/497
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14858272

COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS

IPC classification:
A61K 31/56
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14815381

INSECTICIDAL COMPOUNDS

IPC classification:
A01N 43/00, C07C 255/57
Applicant:
Syngenta Participations AG
Agent:
Syngenta International AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14816261

INSECTICIDAL COMPOUNDS

IPC classification:
A01N 43/00, C07C 237/42, C07C 237/44, C07C 255/57
Applicant:
Syngenta Participations AG
Agent:
Syngenta International AG
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712431

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG1-3

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, G01N 33/53
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712429

ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE

IPC classification:
C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712432

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG4-5

IPC classification:
A61K 39/395, A61P 3/04, A61P 35/00, A61P 37/06, C07K 16/18
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712195

COMBINATION TREATMENT FOR MULTIPLE SCLEROSIS

IPC classification:
C07K 16/30
Agent:
Giorgio Contadin, Notarbartolo & Gervasi SpA
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15829485

AUTHENTICATION DEVICES

IPC classification:
G06F 21/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15831866

ZOLEDRONIC ACID DOSAGE FORMS FOR THE TREATMENT OF PAIN

IPC classification:
A61K 31/197, A61K 31/675, A61P 19/00, A61P 19/02
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15837307

SUBCUTANEOUS WOUND DEBRIDEMENT

IPC classification:
A61B 17/22
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15839010

ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS

IPC classification:
A61K 31/4375, A61K 31/4745, A61K 31/708, A61K 45/00, A61P 35/00, C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15844087

MICRORNA BIOMARKERS FOR POSTTRAUMATIC STRESS DISORDER AND METHODS OF USE THEREOF

IPC classification:
C12N 15/09, C12N 15/113, C12Q 1/68
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15849413

COMPOSITIONS, PANELS AND SHEETS COMPRISING CELLULOSE FILAMENTS AND GYPSUM AND METHODS FOR PRODUCING THE SAME

IPC classification:
B32B 3/12, B32B 13/02, C04B 11/00, C04B 16/02, C04B 28/14, E04C 2/26
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15814003

1 -AMINO-TRIAZOLO(1,5-A)PYRIDINE-SUBSTITUTED UREA DERIVATIVE AND USES THEREOF

IPC classification:
A61K 31/00, C07D 401/04, C07D 403/04, C07D 471/04
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP16713568

IPN VIRUS GENOME MUTATIONS AND CODON INTERACTIONS

IPC classification:
A61K 39/00, A61K 39/12, C07K 14/005, C12N 7/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made

Please Sign in to use this feature